ArticleScientific reports2025
Effects of proximal tubule-specific ATRAP enhancement on hypertension in a remnant kidney chronic kidney disease model of mice.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic kidney disease (CKD) frequently accompanies hypertension, exacerbating CKD progression in a vicious cycle. Angiotensin II type 1 receptor-associated protein (ATRAP) promotes AT1 receptor internalization to inhibit hyperactivation of its downstream signaling. We previously reported that the downregulation of renal ATRAP expression had a critical role in the development of hypertension in a remnant kidney CKD model, through activation of epithelial sodium channel (ENaC) pathway. Although the distal-tubule was highlighted in CKD-related hypertension, the proximal tubule's role remained unclear. We generated proximal tubule-specific ATRAP transgenic (PT-ATRAP Tg) mice under the control of the Npt2 promoter and compared the effects of 5/6 nephrectomy (Nx) on blood pressure (BP) with those in littermate control (LC) wild-type mice. Immunohistochemical and laser microdissection analyses revealed that the proximal tubule-specific overexpression of ATRAP in PT-ATRAP Tg mice resulted in approximately 15-fold increase in ATRAP mRNA expression in the proximal tubules compared to LC mice. There were no significant differences in body weight, systolic BP, heart rate, and renal function between PT-ATRAP Tg and LC mice at baseline before surgery. Furthermore, twelve weeks after surgery, both PT-ATRAP Tg and LC mice that underwent 5/6 nephrectomy showed a similar increase in systolic BP compared to sham-operated mice, with no significant differences. Additionally, 5/6 Nx elevated renal ENaCα expression similarly in both groups. In conclusion, increased ATRAP expression in the proximal tubules does not affect hypertension in the remnant kidney CKD model, suggesting a pathological significance of distal tubules in this disease model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.